- Metabolic syndrome and associated cardiovascular risk factors in the treatment of persons with human immunodeficiency virus and severe mental illnessPamela Vergara-Rodriguez
The Ruth M Rothstein CORE Center, Cook County Health and Hospital System, Chicago, IL 60612, USA
Pharmacol Ther 124:269-78. 2009..Finally, recommendations for monitoring and managing the intersecting, growing population of HIV/AIDS patients with severe mental illness are provided...
- Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patientsPamela Vergara-Rodriguez
The CORE Center, Chicago, IL, USA
J Acquir Immune Defic Syndr 56:S62-7. 2011..The safety of buprenorphine/naloxone (bup/nx) in HIV-infected patients has not been established. Prior reports raise concern about hepatotoxicity and interactions with atazanavir...